首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1391906

白血病篩檢市場：依測試類型、依疾病類型、依年齡層、依最終使用者、按地區

Leukemia Screening Market, By Test Type, By Disease Type, By Age Group, By End User, By Geography

出版日期: 2023年11月08日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2023 年全球白血病篩檢市場規模將達到 72.8 億美元，預計到 2030 年將達到 116.6 億美元，預測期內年複合成長率(CAGR)為 7%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	72.8億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	7.00%	2030年市場規模預測	116.6億美元

圖 1. 2023 年按地區分類的白血病篩檢全球市場佔有率(%)

白血病是一種影響血球的癌症。白血病是一種嚴重的疾病，導致許多人死亡，對家庭和醫療保健系統帶來沉重負擔。白血病的主要診斷工具是實驗室檢查和身體檢查。全血球計數 (CBC) 檢查體內紅血球、白血球和血小板的水平。如果您的異常白血球數量較多，您可能患有白血病。某些類型的白血病細胞在血液中循環，而另一些則保留在骨髓中並且不會出現在常規血液檢查中。由於全球各類白血病發病率不斷上升，全球白血病篩檢市場在過去幾年中出現了顯著成長。白血病是一種始於骨髓的血癌，由異常白血球引起。由於環境污染加劇、生活習慣改變以及世界人口高齡化，白血病患者數量不斷增加。因此，開發中國家對早期發現白血病的先進篩檢測試的需求都在增加。旨在提高人們對白血病的認知和提供創新篩檢解決方案的各種公共和私人舉措正在進一步推動全球白血病篩檢產業的發展。

本研究的主要特點

本報告詳細分析了全球白血病篩檢市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它還闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球白血病篩檢市場的主要企業。
該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
全球白血病篩檢市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球白血病篩檢市場的各種策略矩陣來促進決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
中部非洲
北非

第10章競爭形勢

公司簡介
- F.Hoffmann-La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- QIAGEN NV
- Beckman Coulter, Inc.
- Adaptive Biotechnologies Corporation
- Invivoscribe, Inc.
- ArcherDX, Inc.

第11章章節

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI5859

Global leukemia screening market is estimated to be valued at US$ 7.28 Bn in 2023 and is expected to reach US$ 11.66 Bn by 2030, exhibiting a compound annual growth rate (CAGR) of 7% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 7.28 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.00%	2030 Value Projection:	US$ 11.66 Bn

Figure 1. Global Leukemia Screening Market Share (%), By Region, 2023

Leukemia is a type of cancer that affects blood cells. It is a serious condition that causes a high number of deaths, thereby creating a huge burden on families and the healthcare system. The main diagnostic tools for leukemia are laboratory tests and a physical exam. A complete blood count (CBC) checks the levels of red and white blood cells and platelets in the body. A high level of abnormal white cells can indicate leukemia. Some types of leukemia cells circulate in the blood, while others stay in the bone marrow and do not show up in a routine blood test. The global leukemia screening market has been witnessing notable growth over the past few years due to the rising incidence of different types of leukemia across the world. Leukemia is a type of blood cancer that starts in the bone marrow and results in a high number of abnormal white blood cells. There has been steady rise in leukemia cases due to growing environmental pollution, changing lifestyle habits, and increasing age of the population globally. As a consequence, demand for advanced screening tests for early detection of leukemia has increased in both developed and developing nations. Various public and private initiatives aimed at enhancing awareness about leukemia and availability of innovative screening solutions has further propelled the global leukemia screening industry.

Market Dynamics:

The market is expanding significantly as a result of factors such the increased prevalence of illnesses linked to legionella and pneumonia, as well as the growing need for quick, sophisticated diagnostic methods and developments in bacterial testing technology. A comparatively rare cause of community-acquired pneumonia is legionella pneumonia. For instance, in November 2022, according to a study published titled "Community-Acquired Pneumonia", the expected global incidence of community-acquired pneumonia ranges from 1.5 to 14 cases per 1000 person each year, with region, season, and population characteristics all having a part. Incidence rates rise with age, with 24.8 instances per 10,000 adults in the U.S. each year.

Key features of the study:

This report provides in-depth analysis of the global leukemia screening market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global leukemia screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., QIAGEN N.V., Beckman Coulter, Inc., Adaptive Biotechnologies Corporation, Invivoscribe, Inc., and ArcherDX, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global leukemia screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leukemia screening market

Detailed Segmentation:

Global Leukemia Screening Market, By Test Type
- Complete Blood Count (CBC)
- Bone Marrow Aspiration and Biopsy
- Flow Cytometry
- Cytogenetic Analysis
- Polymerase Chain Reaction (PCR)
- Immunophenotyping
- Others
Global Leukemia Screening Market, By Disease Type
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Others
By Age Group
- Pediatric
- Adult
- Geriatric
By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Others
By Region
- North America
- Europe
- Latin America
- Middle East
- Africa
Top Companies in the Global Leukemia Screening Market:
- F.Hoffmann-La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- QIAGEN N.V.
- Beckman Coulter, Inc.
- Adaptive Biotechnologies Corporation
- Invivoscribe, Inc.
- ArcherDX, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By Disease Type
- Market Snippet, By Age Group
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing incidence of leukemia
- High cost of screening procedures
- Expansion in emerging markets
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Leukemia Screening Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Leukemia Screening Market, By Test Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Complete Blood Count (CBC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Bone Marrow Aspiration and Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Cytogenetic Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Immunophenotyping
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Leukemia Screening Market, By Disease Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Acute Lymphoblastic Leukemia (ALL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Acute Myeloid Leukemia (AML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Chronic Lymphocytic Leukemia (CLL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Chronic Myeloid Leukemia (CML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )

7. Global Leukemia Screening Market, By Age Group, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )

8. Global Leukemia Screening Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Global Leukemia Screening Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
South Africa
Central Africa
North Africa